Pensions & Investments Logo
ETF Exchange > KURE ETF

KURE - ETF Fact Sheet

KraneShares MSCI All China Health Care Index ETF - USD

Fund Identification

Ticker

KURE

ISIN

US5007678353

Main Metrics

Price

$17.75

Expense Ratio

0.79%

AuM

$92.32M

Tracking Difference

-0.70%

Ratings

Trackinsight rating

Official Investment Strategy

KURE seeks to measure the performance of MSCI China All Shares Health Care 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the health care sector. The securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong and United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap and large-cap companies.

KURE's historical prices, performance, and flows

051015%
1m returns
18%
1m flows
$11M
* Net total returns
All data as of 16 July 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all KURE data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

KURE's characteristics

Manager statistics

48 funds, $10.07Bn in AUM

Benchmark

MSCI China All Shares Health Care 10/40 Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
KURE's exposure

Countries

China
86.23%
Switzerland
9.15%

Sectors

Healthcare
98.44%

Top 5 holdings

WuXi AppTec Co., Ltd.
9.19%
BeOne Medicines Ltd.
9.16%
Innovent Biologics, Inc.
8.60%
WuXi Biologics (Cayman), Inc.
7.75%
Akeso, Inc.
4.72%
Total holdings
43
Total weight of top 5
39.42%
15%